Traditional methods for treating intermediate-risk pulmonary embolism (PE), such as anticoagulation, catheter-directed thrombolysis, and mechanical thrombectomy, have long been the standard of care. However, these treatments come with significant challenges. Patients often face prolonged hospital stays, lengthy recovery times, and a higher risk of complications. Additionally, these procedures may place considerable strain on hospital resources, which can increase healthcare costs. As a result, there has been a growing need for more efficient and effective solutions that can improve patient outcomes while reducing the burden on healthcare systems.
Enter Penumbra’s innovative solution: the computer-assisted vacuum thrombectomy (CAVT) technology. Recently unveiled at the Vascular Interventional Advances (VIVA) 2024 conference, Penumbra’s Lightning Flash and Lightning 12 devices represent a major advancement in PE treatment. These devices utilize a unique combination of pressure and flow-based processes, powered by a microprocessor with thrombus removal algorithms, to detect and remove blood clots more efficiently than traditional methods.
The technology is designed to streamline the thrombectomy procedure by offering real-time audio-visual feedback, which guides clinicians in the removal of clots. This results in quicker, more precise interventions, reducing the time patients spend in the hospital and shortening post-procedure recovery. A recent retrospective study, which analyzed 2,060 adult patients with intermediate-risk PE, demonstrated that those treated with Penumbra’s CAVT technology experienced fewer complications and a significantly shorter length of stay compared to those undergoing traditional treatments.
Moreover, the study found that in-hospital mortality rates were low and showed no significant difference between CAVT and other treatment options, reinforcing the safety and effectiveness of the technology. Penumbra’s Chief Medical Officer, James Benenati, highlighted the added benefit of reducing hospital resource utilization, which ultimately lowers overall healthcare costs.
Article written by Robert Barrie
06/11/2024
Source:
Medical device